Journal of the Association of Genetic Technologists
Overview
Journal of the Association of Genetic Technologists is a scientific journal, published since 1998 in English. The journal's country of origin is United States.
Details
Details
Abbr.
J Assoc Genet Technol
Start
1998
End
Continuing
Frequency
Quarterly, 2000-
p-ISSN
1523-7834
Country
United States
Language
English
Recent Articles
1.
Garcia-Heras J
J Assoc Genet Technol
. 2025 Mar;
51(1):5-10.
PMID: 40023831
The Nobel Assembly of the Karolinska Institute (Sweden) awarded the 2024 Nobel Prize in Physiology or Medicine to Dr. Victor Ambros (University of Massachusetts Chan Medical School, Worcester, United States)...
2.
Cherukuri S, Li L, Soff S, Andrzejczyk A, Ahmed T
J Assoc Genet Technol
. 2025 Mar;
51(1):21-24.
PMID: 40023830
IgD myeloma is a rare subset of multiple myeloma characterized by the production of monoclonal IgD protein. This subset of myeloma generally has a more severe and aggressive clinical course....
3.
Tirado C, Mian R, Gallagher L, Ponce R, Lee H, Fernicola P, et al.
J Assoc Genet Technol
. 2025 Mar;
51(1):12-20.
PMID: 40023829
Acute myeloid leukemia (AML) is a heterogeneous disease, indicated by its many conceivable cytogenetic mutations. Hyperdiploidy is a rare abnormality in AML, more prevalent in children than adults, with few...
4.
Ruggero A, Tirado C
J Assoc Genet Technol
. 2024 Dec;
50(4):183-187.
PMID: 39645613
16p11.2 deletion syndrome is a rare genetic abnormality that affects an individual's cognitive abilities. 16p11.2 deletion syndrome is characterized by a loss of region 11.2 on chromosome 16, which includes...
5.
Hassan F, Tirado C
J Assoc Genet Technol
. 2024 Dec;
50(4):179-181.
PMID: 39645612
Acute myeloid leukemia, myelodysplasia-related (AML-MR) is a particularly aggressive and adverse subtype of acute myeloid leukemia, predominantly affecting older adults who often face complex treatment challenges and poor prognoses. The...
6.
Roush S, Ahmed T, Schuster M, Wang K, Lee E, Zavala A, et al.
J Assoc Genet Technol
. 2024 Dec;
50(4):193-198.
PMID: 39645611
We report a 76-year-old male patient with myelodysplastic syndrome (MDS) with a t(9;22) and deletion 20q only by FISH. Past medical history is significant for prostate cancer status post radiation...
7.
Gardner J, Sprague J, Greipp P, Conant J
J Assoc Genet Technol
. 2024 Dec;
50(4):188-192.
PMID: 39645610
Lenalidomide, a derivative of thalidomide, is a type of immunomodulatory drug (IMiD) that has been standard therapy for multiple myeloma (MM) and other hematologic malignancies for almost two decades. The...
8.
White J, Clark M, Tuller E, McCurrin C, Cline L, Tirado C
J Assoc Genet Technol
. 2024 Sep;
50(3):104-113.
PMID: 39222522
B-cell acute lymphoblastic leukemia (B-ALL) is the most prevalent cancer in United States children. In recent years, immunotherapies using chimeric antigen receptors (CAR T-cells) have improved prognosis for patients with...
9.
Garcia-Heras J
J Assoc Genet Technol
. 2024 Sep;
50(3):96-99.
PMID: 39222521
Two recent studies that re-examined through novel approaches previous shotgun sequencing data from prehistoric/historic Europeans uncovered several autosomal and sex chromosome aneuploidies (Anastasiadou et al., 2024; Rohrlach et al., 2024)....
10.
Ruggero A, Clark M, Lewkowski A, Hurtado R, Tirado C
J Assoc Genet Technol
. 2024 Sep;
50(3):114-126.
PMID: 39222520
Bladder cancer is a highly heterogeneous malignancy, affecting 600,000 people annually. Approximately 66% of patients will recur within five years; accordingly, accurate diagnosis and intensive surveillance of bladder cancer are...